amlodipine/hydrochlorothiazide/ramipril

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nameamlodipine/hydrochlorothiazide/ramipril

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitorsAngiotensin-converting enzyme inhibitors

TargetsVoltage-gated calcium channelThiazide-sensitive sodium-chloride cotransporterAngiotensin-converting enzyme

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Amlodipine Besylate Hydrochlorothiazide Ramipril

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSandoz Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeC09BX03